Bassiouny, A. R., Atteya, M. A., El-Rashidy, F. H. & Neenaa, H. M. (2011). Curcumin and EGCG Suppress Apurinic/Apyrimidinic Endonuclease 1 and Induce Complete Remission in B-cell Non-Hodgkin's lymphoma Patients. Functional Foods in Health and Disease, 1(12):525-544 Kanai, M., Yoshimura, K., Asada, M., Imaizumi, A., Suzuki, C., Matsumoto, S. et al. (2011, July). A phase I/II study of [von Google zensierter Begriff]-based chemotherapy plus curcumin for patients with [von Google zensierter Begriff]-resistant pancreatic cancer. Cancer chemotherapy and pharmacology, 68(1):157-64, doi: 10.1007/s00280-010-1470-2 Carroll, R. E., Benya, R. V., Turgeon, D. K., Vareed, S., Neuman, M., Rodriguez, L. et al. (2011, March). Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer prevention research (Philadelphia), 4(3):354-64, doi: 10.1158/1940-6207.CAPR-10-0098 Rai, B., Kaur, J., Jacobs, R. & Singh, J. (2010, June). Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. Journal of oral science, 52(2):251-6 Epelbaum, R., Schaffer, M., Vizel, B., Badmaev, V. & Bar-Sela, G. (2010). Curcumin and [von Google zensierter Begriff] in patients with advanced pancreatic cancer. Nutrition and cancer, 62(8):1137-41, doi: 10.1080/01635581.2010.513802 Bayet-Robert, M., Kwiatkowski, F., Leheurteur, M., Gachon, F., Planchat, E., Abrial, C. et al. (2010, January). Phase I dose escalation trial of [von Google zensierter Begriff] plus curcumin in patients with advanced and metastatic breast cancer. Cancer biology & therapy, 9(1):8-14 Adiwidjaja, J. McLachlan, A. J. & Boddy, A. V. (2017, September). Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions, Expert Opinion on Drug Metabolism & Toxicology, 13(9):953-972, doi: 10.1080/17425255.2017.1360279 Zhou, S., Yao, D., Guo, L. & Teng, L. (2017, June). Curcumin suppresses gastric cancer by inhibiting gastrin-mediated acid secretion. FEBS Open Bio, 7(8):1078-1084, doi: 10.1002/2211-5463.12237 Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Majeed, M. & Sahebkar, A. (2015, December). Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clinical Nutrition, 34(6):1101-8, doi: 10.1016/j.clnu.2014.12.019 Zhao, X., Wang, C., Zhang, JF. et al. Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor. Psychopharmacology 231, 2171–2187 (2014). https://doi.org/10.1007/s00213-013-3368-2
Bassiouny, A. R., Atteya, M. A., El-Rashidy, F. H. & Neenaa, H. M. (2011). Curcumin and EGCG Suppress Apurinic/Apyrimidinic Endonuclease 1 and Induce Complete Remission in B-cell Non-Hodgkin's lymphoma Patients. Functional Foods in Health and Disease, 1(12):525-544 Kanai, M., Yoshimura, K., Asada, M., Imaizumi, A., Suzuki, C., Matsumoto, S. et al. (2011, July). A phase I/II study of [von Google zensierter Begriff]-based chemotherapy plus curcumin for patients with [von Google zensierter Begriff]-resistant pancreatic cancer. Cancer chemotherapy and pharmacology, 68(1):157-64, doi: 10.1007/s00280-010-1470-2 Carroll, R. E., Benya, R. V., Turgeon, D. K., Vareed, S., Neuman, M., Rodriguez, L. et al. (2011, March). Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer prevention research (Philadelphia), 4(3):354-64, doi: 10.1158/1940-6207.CAPR-10-0098 Rai, B., Kaur, J., Jacobs, R. & Singh, J. (2010, June). Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. Journal of oral science, 52(2):251-6 Epelbaum, R., Schaffer, M., Vizel, B., Badmaev, V. & Bar-Sela, G. (2010). Curcumin and [von Google zensierter Begriff] in patients with advanced pancreatic cancer. Nutrition and cancer, 62(8):1137-41, doi: 10.1080/01635581.2010.513802 Bayet-Robert, M., Kwiatkowski, F., Leheurteur, M., Gachon, F., Planchat, E., Abrial, C. et al. (2010, January). Phase I dose escalation trial of [von Google zensierter Begriff] plus curcumin in patients with advanced and metastatic breast cancer. Cancer biology & therapy, 9(1):8-14 Adiwidjaja, J. McLachlan, A. J. & Boddy, A. V. (2017, September). Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions, Expert Opinion on Drug Metabolism & Toxicology, 13(9):953-972, doi: 10.1080/17425255.2017.1360279 Zhou, S., Yao, D., Guo, L. & Teng, L. (2017, June). Curcumin suppresses gastric cancer by inhibiting gastrin-mediated acid secretion. FEBS Open Bio, 7(8):1078-1084, doi: 10.1002/2211-5463.12237 Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Majeed, M. & Sahebkar, A. (2015, December). Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clinical Nutrition, 34(6):1101-8, doi: 10.1016/j.clnu.2014.12.019 Zhao, X., Wang, C., Zhang, JF. et al. Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor. Psychopharmacology 231, 2171–2187 (2014). https://doi.org/10.1007/s00213-013-3368-2